Trends in the utilization of imaging for upper tract urothelial carcinoma

被引:14
作者
Mohapatra, Anand [1 ]
Vemana, Goutham [2 ]
Bhayani, Sam [1 ]
Baty, Jack [3 ]
Vetter, Joel [1 ]
Strope, Seth A. [1 ]
机构
[1] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA
[2] Urol Associates Houston, Houston, TX USA
[3] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
Upper Tract Urothelial Cancer; Imaging; Diagnosis; Endoscopy; Surgery; TRANSITIONAL-CELL-CARCINOMA; BOLUS MDCT UROGRAPHY; TOMOGRAPHY UROGRAPHY; CT UROGRAPHY; GUIDELINES; OUTCOMES;
D O I
10.1016/j.urolonc.2015.12.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To evaluate the changes in use of the different imaging modalities for diagnosing upper tract urothelial carcinoma (UTUC) and assess how these changes have affected tumor stage at the time of surgery. Materials and methods: We assessed the Surveillance, Epidemiology, and End Results (SEER) cancer registry and linked Medicare claims data (1992-2009) for 5377 patients who underwent surgery for UTUC. We utilized International Classification of Disease Oncology 3 codes to identify UTUC. International Classification of Disease, ninth Revision, Clinical Modification and Current Procedure Terminology codes identified surgical treatment and imaging modalities. We assessed for use of intravenous pyelography, retrograde pyelography (RGP), computed tomography urography (CTU), magnetic resonance urography (MRU), and endoscopy. For each modality, patients were categorized as having received the modality at least once or not at all. Patient characteristics were compared using chi-squared tests. Usage of imaging modalities and tumor stage was trended using Cochran-Armitage tests. We stratified our data into 2 multivariate logistic regression models to determine the effect of imaging modalities on tumor stage: 1992 to 1999 with all modalities except MRU, and 2000 to 2009 with all modalities. Results: Our patient population was predominantly White males of more than 70 years old. Intravenous pyelography and RGP declined in use (62% and 72% in 1992 vs. 6% and 58% in 2009, respectively) while computed tomography urography, MRU, and endoscopy increased in use (2%, 0%, and 37% in 1992 vs. 44%, 6%, and 66% in 2009, respectively). In both regression analyses, endoscopy was associated with lower-stage tumors. In the 2000 to 2009 model, RGP was associated with lower-stage tumors, and MRU was associated with higher-stage tumors. Finally, our data showed an increasing number of modalities utilized for each patient (1% receiving 4 modalities in 1992 vs. 20% in 2009). Conclusions: We found trends toward the utilization of newer imaging modalities to diagnose UTUC and more modalities per patient. Endoscopy and RGP were associated with smaller tumors, whereas MRU was associated with larger tumors. Further studies are needed to evaluate the utility of the different modalities in diagnosing UTUC. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:236.e23 / 236.e28
页数:6
相关论文
共 50 条
  • [41] Diagnosis and Management of Upper Tract Urothelial Carcinoma
    Lucca, Ilaria
    Leow, Jeffrey J.
    Shariat, Shahrokh F.
    Chang, Steven L.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (02) : 271 - +
  • [42] The role of surgery on primary site in metastatic upper urinary tract urothelial carcinoma and a nomogram for predicting the survival of patients with metastatic upper urinary tract urothelial carcinoma
    Zhang, Xiaodi
    Wang, Ping
    Qi, Kaiyan
    Qiao, Qiao
    Jiang, Yuanjun
    CANCER MEDICINE, 2021, 10 (22): : 8079 - 8090
  • [43] Comparison of clinicopathological features in metastatic upper tract urothelial carcinoma and urothelial bladder cancer
    Xie, Jing
    Zhang, Xue-Bin
    Wen, Jin
    Zhang, Yu-Shi
    Li, Han-Zhong
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (04) : 481 - 487
  • [44] Intracavitary therapies for upper tract urothelial carcinoma
    Knoedler, John J.
    Raman, Jay D.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (05) : 487 - 493
  • [45] The role of lymphadenectomy for upper tract urothelial carcinoma
    Messer, Jamie
    Lin, Yu Kuan
    Raman, Jay D.
    NATURE REVIEWS UROLOGY, 2011, 8 (07) : 394 - 401
  • [46] Therapeutic strategies for upper tract urothelial carcinoma
    Freifeld, Yuval
    Krabbe, Laura-Maria
    Clinton, Timothy N.
    Woldu, Solomon L.
    Margulis, Vitaly
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (08) : 765 - 774
  • [47] Advanced upper urinary tract urothelial carcinoma is indistinguishable from renal infection by imaging: A case report
    Chai, Jiagui
    Feng, Runlin
    Li, Yuhang
    Ke, Changxing
    MEDICINE, 2024, 103 (37) : e39651
  • [48] A preoperative magnetic resonance imaging can aid in staging and treatment choice for upper tract urothelial carcinoma
    Almas, Bjarte
    Reisaeter, Lars Anders Rokne
    Markhus, Carl Erik
    Hjelle, Karin Margrethe
    Borretzen, Astrid
    Beisland, Christian
    BJUI COMPASS, 2024, 5 (05): : 476 - 482
  • [49] European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update
    Roupret, Morgan
    Babjuk, Marko
    Comperat, Eva
    Zigeuner, Richard
    Sylvester, Richard
    Burger, Max
    Cowan, Nigel
    Boehle, Andreas
    Van Rhijn, Bas W. G.
    Kaasinen, Eero
    Palou, Joan
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY, 2013, 63 (06) : 1059 - 1071
  • [50] Impact of surgical waiting time on survival in patients with upper tract urothelial carcinoma: A national cancer database study
    Xia, Leilei
    Taylor, Benjamin L.
    Pulido, Jose E.
    Guzzo, Thomas J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (01) : 10.e15 - 10.e22